I have a close friend who runs clinical trials for a biotech company. This is her area of expertise. She has had entire trials cancelled when 1 person has died from the drug. So the tact they are taking with AZ and J&J is a lot more lenient than normal. Not that I disagree with it, but understand that there are drugs that have been cancelled for less than what these drugs are exhibiting.